Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01CX002499-01 |
| Title: | Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer |
| Principal Investigator: | Daniel Shin |
| Location: | West Los Angeles, CA |
| Congressional District Code: | 33 |
| Research Service: | Clinical Science R&D |
| Project Period: | January 2024 - December 2027 |
| FY 2025 Funding Amount: | $713,378 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |